92.49 USD
▲+1.34+5.44%
盘后 89.00 +1.46%
2026-08-03
市值
$4.51B
市盈率
—
EPS
-3.89
股息率
—
52 周区间
38.93 – 151.02
成交量
713.87K
Beta
0.16
目标价
163.54
52W 低 38.9352W 高 151.02
价格走势
公司简介
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic...